Analyzing Nuwellis (NUWE) and Its Peers

Nuwellis (NASDAQ:NUWE) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its competitors? We will compare Nuwellis to similar companies based on the strength of its institutional ownership, earnings, valuation, analyst recommendations, risk, dividends and profitability.

Volatility and Risk

Nuwellis has a beta of 0.03, meaning that its share price is 97% less volatile than the S&P 500. Comparatively, Nuwellis’ competitors have a beta of 2.56, meaning that their average share price is 156% more volatile than the S&P 500.

Profitability

This table compares Nuwellis and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nuwellis	-123.38%	-623.14%	-147.34%
Nuwellis Competitors	-278.24%	-150.08%	-21.87%

Analyst Recommendations

This is a breakdown of current ratings and price targets for Nuwellis and its competitors, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nuwellis	1	0	0	0	1.00
Nuwellis Competitors	4270	10539	18313	828	2.46

As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.08%. Given Nuwellis’ competitors stronger consensus rating and higher possible upside, analysts plainly believe Nuwellis has less favorable growth aspects than its competitors.

Earnings & Valuation

This table compares Nuwellis and its competitors top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Nuwellis	$8.27 million	-$17.52 million	-0.00
Nuwellis Competitors	$1.87 billion	$138.21 million	9.47

Nuwellis’ competitors have higher revenue and earnings than Nuwellis. Nuwellis is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Institutional & Insider Ownership

3.1% of Nuwellis shares are held by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 1.6% of Nuwellis shares are held by company insiders. Comparatively, 14.8% of shares of all “Healthcare Equipment & Supplies” companies are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Nuwellis competitors beat Nuwellis on 12 of the 13 factors compared.

Nuwellis Company Profile

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.